Skip to content

Cannabis: all studies

Page 289 of 294: studies 2,881 to 2,890 of 2,937, newest first. Back to the cannabis overview

Research

Cannabinoid receptor localization in brain.

Proceedings of the National Academy of Sciences March 1990 M Herkenham, A B Lynn, M D Little et al.

[3H]CP 55,940, a radiolabeled synthetic cannabinoid, which is 10-100 times more potent in vivo than delta 9-tetrahydrocannabinol, was used to characterize and localize a specific cannabinoid receptor in brain sections. The potencies of a series of natural and synthetic cannabinoids as competitors of [3H]CP 55,940 binding correlated closely with their relative potencies in several biological...

Second Thoughts on 3,4-Methylenedioxymethamphetamine (MDMA) Neurotoxicity

Archives of General Psychiatry March 1, 1990 Charles S. Grob 34 citations

To the Editor.— Recent attention has been drawn to the purported neurotoxic dangers associated with 3, 4-methylenedioxymethamphetamine (MDMA). Price et al1have attempted to assess possible serotonergic neurotransmitter damage by contrasting serum prolactin response to the challenge with intravenous L-tryptophan in subjects with a history of MDMA use vs control subjects. Their primary finding...

Clinical features and management of intoxication due to hallucinogenic drugs.

Medical toxicology and adverse drug experience 1989 J B Leikin, A J Krantz, M Zell-Kanter et al.

Hallucinogenic drugs are unique in that they produce the desired hallucinogenic effects at what are considered non-toxic doses. The hallucinogenic drugs can be categorised into 4 basic groups: indole alkaloid derivatives, piperidine derivatives, phenylethylamines and the cannabinols. The drugs reviewed include lysergic acid diethylamide (LSD), phencyclidine (PCP), cocaine, amphetamines,...

Period, age, and cohort effects on substance use among young Americans: a decade of change, 1976-86.

American Journal of Public Health October 1, 1988 Patrick M. O’malley, Jerald G. Bachman, Lloyd D. Johnston 111 citations

In an earlier article in this Journal, we reported analyses that differentiated among period, age, and cohort effects on substance use among American youth 18 to 24 years old, from the high school classes of 1976 to 1982 during the period of 1976 to 1982. The present analyses extend the classes and years to 1986, and the age range to 18-28. A cohort-sequential design is employed, based on...

DOI: 10.2105/ajph.78.10.1315 (opens in new tab) Full text (opens in new tab) Heroin Methaqualone Demography Cohort study +6

Medical Toxicology: Diagnosis and Treatment of Human Poisoning.

Annals of Internal Medicine March 1, 1988 957 citations

General Approach to the Poisoned Patient Introduction and Initial Evaluation. Diagnostic Services. Gut Decontamination. Enhancement and Elimination. Antidotes. Supportive Care. Pharmacokinetics. Toxic Exposure During Pregnancy. Therapeutic Drugs Acetaminophen. Anti-Arrhythmic Agents. Anti-Coagulants. Anti-Convulsants. Anti-Hypertensive Drugs. Anti-Infective Drugs. Anti-Depressants. Disulfiram....

DOI: 10.7326/0003-4819-108-3-502_9 (opens in new tab) Clinical toxicology Intensive care medicine Medical emergency Poison control

Hallucinogenic Mushrooms

Clinical Pediatrics February 1, 1988 Richard H. Schwartz, D. E. Smith 51 citations

Ingestion of mushrooms containing psilocybin produces hallucinogenic effects and has become a popular form of substance abuse among some adolescents and young adults. We have reviewed the medical literature on psilocybin mushrooms and describe current patterns of use, provide background material on the botony and pharmacology of these crude drugs, and report results of a small study on usage...

DOI: 10.1177/000992288802700202 (opens in new tab) Psilocybin Hallucinogen Substance abuse Ingestion +3

Parental, Personality, and Peer Correlates of Psychoactive Mushroom Use

Journal of Drug Education September 1, 1986 M. Douglas Anglin, John P. Thompson, Dennis Gene Fisher 13 citations

Fifty-three college undergraduates reporting use of a hallucinogenic mushroom ( Psilocybe) were matched on demographic variables to fifty-three nonusers. The subjects were given a detailed questionnaire and were administered four psychological tests. Hallucinogenic mushroom use by men was most associated with peers' mushroom use, whereas mushroom use by women was most associated with parental...

Attitude and personality correlates of hallucinogenic drug use.

International Journal of the Addictions June 1986 E A Mabry, K A Khavari

Personality, attitude, and hallucinogenic drug use data were obtained from 298 male and female adult members of labor unions. Multiple regression and canonical correlation analyses of drug use, personality, and attitude data revealed that: the use of hallucinogens was significantly related to needs for novel or unconventional experiences and negative attitudes toward conventionally defined...

Cellular effects of cannabinoids.

Pharmacological Reviews March 1, 1986 B. Martin

The many studies that have been included in this review suggest that cannabinoids have ubiquitous effects on biological systems. These results also underscore the intensity to which cannabinoids have been studied. While there are numerous reasons for the prodigious amount of cannabinoid research, a major stimulus has been the desire to identify a specific biochemical event or pathway that is...

Discriminative stimulus properties and brain distribution of phencyclidine in rats following administration by injection and smoke inhalation.

Pharmacology, Biochemistry, and Behavior October 1985 W D Wessinger, B R Martin, R L Balster

Four male Sprague-Dawley rats were trained to discriminate IP injections of 3.0 mg/kg phencyclidine (PCP) from saline under a 2-lever fixed-ratio 32 schedule of food presentation. After reliable discriminative control of lever choice was established, other doses of injected PCP were tested resulting in dose-dependent increases in PCP-lever selection and dose-dependent decreases in rates of...